title: Chronic viral hepatitis.
abstract: Chronic liver disease is the tenth leading cause of death in the United States. The economic burden of liver disease is approximately 1% of the total national health care expenditure. Chronic hepatitis C is the most common cause of chronic liver disease in the United States, and chronic hepatitis B is the leading cause of liver disease worldwide. This article provides a brief overview of the evaluation and treatment of chronic hepatitis B and C infection.
authors.affiliation: Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, USA.
authors.forename: Noma
authors.initials: N
authors.lastname: Dakhil
authors.forename: Omer
authors.initials: O
authors.lastname: Junaidi
authors.forename: Alex S
authors.initials: AS
authors.lastname: Befeler
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D000075202:Contraindications; D024882:Drug Resistance, Viral; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans
chemical_list: D000998:Antiviral Agents